Showa Denko provisions LEDs for research on MucoRice Oral Vaccine

TOKYO, Apr 24, 2018 - (JCN Newswire) - Showa Denko (SDK) has entered into an agreement with Astellas Pharma Inc. supporting its research on the practical applications of MucoRice-CTB, a rice-based oral vaccine, to be carried out with the Institute of Medical Science, the University of Tokyo, Chiba University and Asahi Kogyosha.

SDK will be responsible for providing Astellas with LED lighting and related equipment for plant growth, contributing to the development of MucoRice with know-how nourished through years of experience in plant factories.

Showa Denko's LED lighting systems for plant growth include LEDs that emit deep-red light with wavelengths of 660 nm, the optimal light for photosynthesis, with the highest levels of efficiency yet measured, and LEDs which emit blue light.

Using an S-method (SHIGYOTM Method) which irradiates deep-red and blue lights alternately in optimized cycles, the system creates an environment that allows a lettuce to grow to 150 grams only 30 days after seeding.

The system's equipment not only controls the lighting environment as desired, but applies to a variety of plant growth strategies as well. For more information, please visit www.sdk.co.jp/english/ or contact the SDK Public Relations Office at +81-3-5470-3235.

 
Copyright 2018 JCN Newswire. All rights reserved. www.jcnnewswire.com
Purchase this article for republication.

BRANDED CONTENT

SPONSORED CONTENT

Your daily good stuff - AsiaOne stories delivered straight to your inbox
By signing up, you agree to our Privacy policy and Terms and Conditions.